Zydus acquires gastro drug 'Actibile' from Kolkata-based Albert David
This is the Group's second acquisition this year after it had acquired select brands of Zoetis in January28-03-2016
28-03-2016
Zydus Pharma Inc recalls 9,504 bottles of Risperidone tablets
The USFDA said the reason for recall is 'out of specification for a known degradant'07-03-2016
Fixes Record Date for Interim Dividend
Zydus Wellness Ltd has informed BSE that the Company has fixed March 17, 2016 as the Record Date for the purpose of Payment of Interim Dividend.Further, the interim dividend shall be paid to the shareholders entitled thereto, on and from, March 21, 2016.04-03-2016
Board declares Interim Dividend
Zydus Wellness Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 04, 2016, has approved payment of interim dividend @ of 65% i.e. Rs. 6.5/- per equity share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the financial year 2015-2016.04-03-2016
Board to consider Interim Dividend
Zydus Wellness Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 04, 2016, to consider, the proposal for declaration of Interim Dividend, if any, for the financial year 2015-2016 and fixing Record Date for the purpose.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will...01-03-2016
Zydus gets final USFDA nod for anti-diabetic Glyburide, Metformin
Pharma major Cadila Healthcare Ltd (Zydus Cadila)on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) to market anti-diabetic drugs called ...01-03-2016
Zydus gets USFDA nod to market Doxycycline Capsules USP
Zydus Cadila on Friday announced that the company has received approval from the US drug regulator, US Food and Drug Administration to market Doxycycline Capsules USP. In a statement here, the co...19-02-2016
Indians are late to the biologicals party
but because of that, we can use newer and better technology, says Zydus Cadilas COO14-02-2016
Financial Results with Results Press Release & Limited Review Report for Dec 31, 2015
Zydus Wellness Ltd has informed BSE about :1. Financial Results for the period ended December 31, 2015 (Standalone and Consolidated).2. Limited Review Report for the period ended December 31, 2015 (Standalone and Consolidated).3. Results Press Release.04-02-2016
Board Intimation for Results & Closure of Trading Window
Zydus Wellness Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 04, 2016 to consider apart from other agenda items to approve the unaudited financial results [limited reviewed] for the quarter / nine months ended on December 31, 2015.Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 2015, the...20-01-2016